October 29, 2013
Though an Arkansas federal court dismissed drug defect claims against an Indian manufacturer on Monday, attorneys believe more and more plaintiffs injured by generic drugs could go after foreign contract manufacturers in their desperate attempt to find defendants unprotected by the U.S. Supreme Court's Mensing and Bartlett decisions.